Updated: May 19, 2026

Thomas Desrosier

MCRBSeres Therapeutics, Inc.SEC CIK: 0001435744
Estimated Net Worth
$3.76 Million
Last Updated: May 19, 2026 11:37 PM EST

Transaction Summary

Total Transactions49
Buy-Sell Ratio1.20
Buy Transactions24
Sell Transactions20

Transaction Volume

Total Volume$16.39M
Net Volume-$13.1M
Buy Volume$1.65M
Sell Volume$14.75M

Trade Analysis

AVG Trade Size$334.57K
Largest Trade$12.33M
Most Active MonthFeb
Most Active Year2014

Trading Sentiment

OverallBearish
Recent TradeBuying
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading chart

Monthly Trading Pattern

Loading chart

Past Insider Trading and Trends

Thomas Desrosier has an estimated net worth of $3.76 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Seres Therapeutics, Inc., ARIAD PHARMACEUTICALS INC, and CUBIST PHARMACEUTICALS INC.



2014 was Thomas Desrosier's most active year for acquiring shares with 11 total transactions. Thomas Desrosier's most active month to acquire stocks was the month of January. 2011 was Thomas Desrosier's most active year for disposing of shares, totalling 17 transactions. Thomas Desrosier's most active month to dispose stocks was the month of March. 2010 saw Thomas Desrosier paying a total of $1,186,917.76 for 28,871 shares, this is the most they've acquired in one year. In 2011 Thomas Desrosier cashed out on 224,430 shares for a total of $12,333,384.76, their largest year based on trade value.

Holdings & Transactions

Loading…
Loading…
Loading…
Loading…